Switch to:
More From Other Websites
Regeneron, Sanofi rheumatoid arthritis drug wins U.S. approval May 22 2017
Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately... May 22 2017
Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately... May 22 2017
Sanofi Wins Favorable CHMP Opinion for Biosimilar Humalog May 22 2017
Regeneron And Sanofi Have A Near-Term FDA Catalyst May 22 2017
Merck vs. Sanofi: Which Stock is a Better Pick Post Q1 Earnings? May 22 2017
Blog Coverage: CHMP Okays French Pharma Major Sanofi's Insulin Lispro Biosimilar for Treatment of... May 22 2017
Bull of the Day: Regeneron (REGN) May 17 2017
[$$] Big pharma hopes rule change will ease China sales pain May 16 2017
Post Earnings Coverage as Merck's EPS Surged 40%; Raised Outlook May 15 2017
Henri Termeer, 'giant of biotech' and longtime CEO of Genzyme, dies at 71 May 14 2017
Sanofi : SNY-US: Dividend Analysis : May 15th, 2017 (record date) : By the numbers : May 12, 2017 May 12 2017
Is Regeneron Pharmaceuticals Stock Still a Buy After Its Big Bounce? May 12 2017
There could a better way to protect against the flu, and it has implications for tackling HIV and... May 11 2017
Allegra® Allergy Gears Up for Bike to Work Day Across the U.S. May 11 2017
Another top executive at ​Sanofi Genzyme leaves company May 10 2017
Mylan Q1 Revenue Falls Short Of Views As EpiPen Sales Decline May 10 2017
Sanofi: Annual General Shareholders' Meeting of May 10, 2017 May 10 2017
Sanofi says has no "absolute need" to do acquisitions May 10 2017
Sanofi pegs U.S. drug price rises to below healthcare inflation May 09 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK